Target Corporation d/b/a Target

I'll verify the company profile and the plaintiff in the tracked case.

Company overview. Target Corporation (doing business as Target; NYSE: TGT) is a publicly traded general merchandise retailer headquartered at 1000 Nicollet Mall, Minneapolis, Minnesota. Its corporate lineage dates to 1902 (the Dayton's department store company), with the first Target store opening in 1962 and the stock listed in 1972. It is not a subsidiary and has no parent. Public sources put headcount at roughly 415,000 employees, with fiscal 2025 net sales of about $104.8 billion (year ended Jan. 31, 2026) and market capitalization in the $55–75 billion range depending on date.

Products / services / operations. Target is an operating company, not an NPE. It operates roughly 2,000 U.S. stores selling general merchandise across apparel and accessories, beauty and household essentials, food and beverage, hardlines, and home furnishings. About 30% of sales come from owned and exclusive private-label brands. Physical stores fulfill more than 97% of merchandise sales and double as fulfillment hubs for digital orders; the company also sells through its website and app, including same-day fulfillment services. All sales are U.S.-derived.

Patent-litigation posture. In the tracked data Target appears once, exclusively as a defendant (0 plaintiff cases, 1 defendant case). That pattern is consistent with a large operating company defending against third-party patent assertions rather than a party asserting its own portfolio. The single matter was filed in the U.S. District Court for the District of Minnesota — Target's home venue — not in a plaintiff-friendly district such as the Eastern District of Texas.

Notable case. Innercap Technologies, Inc. v. Target Corporation d/b/a Target, No. 0:26-cv-02427 (D. Minn., filed Apr. 30, 2026), assigned to District Judge Nancy E. Brasel with Magistrate Judge David T. Schultz. Innercap asserts U.S. Patent 7,670,612, "Multi-phase, multi-compartment capsular delivery apparatus and methods for using same," and press coverage of the filing identifies Target's sale of Ritual vitamin products as the accused activity. Innercap is a small capsule drug-delivery developer with a limited patent portfolio; a May 2026 retail patent litigation report lists it among that month's frequent filers, though the case docket shows no parent or publicly held owner. The merits are not assessed here.